A multicenter European survey of the attitudes to contraception in women at high risk or with established cardiovascular disease

European Journal of Contraception and Reproductive Health Care

Volumn 1, Issue 3, 1996, Pages 267-273

  Creatsas, G ^a   Pitsavos, C ^a   Amy, J J ^a   Aubeny, E ^a   Bartfai, G ^a   Coll, C ^a   Elstein, M ^a   Eskes, T ^a   Kovacs, L ^a   Lazdane, G ^a   Lidegaard, O ^a   Winkler, U H ^a   Unzeitig, V ^a  

^a NONE

Author keywords

Cardiovascular disease; Contraception; Coronary disease; Oral contraceptives

Indexed keywords

ADULT; AFTERCARE; ARTICLE; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTRACEPTION; DRUG CONTRAINDICATION; DRUG MONITORING; EUROPE; FEMALE; GYNECOLOGY; HEALTH PERSONNEL ATTITUDE; HEALTH STATUS; HUMAN; METHODOLOGY; MULTICENTER STUDY; PHYSICIAN; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK FACTOR; STATISTICS;

ADULT; AFTERCARE; ATTITUDE OF HEALTH PERSONNEL; CARDIOVASCULAR DISEASES; CONTRACEPTION; DRUG MONITORING; EUROPE; FEMALE; GYNECOLOGY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; QUESTIONNAIRES; RISK FACTORS;

EID: 0030223346     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.3109/13625189609150669     Document Type: Article

References (18)

1. Norris L. Sex steroids and changes in the cardiovascular system. I. Changes in systems relevant for development of cardiovascular disease. Annotation of Esbjerg I Consensus meeting. Gynecol Endocrinol 1996; 10 (Suppl 2): 45-7
2. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case control study. Lancet 1995; 346: 1575-82
3. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestogens in low-estrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582-6
4. Lidegaard O, Nilson J. The pill. The controversy continues. Acta Obstet Gynecol Scand 1996; 75: 93-7
5. Shapiro S, Slone D, Rosenberg L, et al. Oral contraceptive use in relation to myocardial infarction. Lancet 1979; 1: 743-7
6. Rosenberg L, Kaufman DW, Helmich SP, et al. Myocardial infarction and cigarette smoking in women younger than 50 years of age. J Am Med Assoc 1985; 253: 2965-9
7. Stampfer MJ, Willett WC, Colditz CA, et al. Past use of oral contraceptives and cardiovascular disease: a meta-analysis in content of the Nurses' Health study. Am J Obstet Gynecol 1990; 163: 285-91
8. Creatsas G. Progestogens in reproductive endocrinology. Eur J Obstet Gynecol Biol Reprod 1991; 41: 28
9. Winkler UH. Role of screening for vascular disease in pill users: the hemostatic system evidence on acute long-term effects. In Hannaford PC, Webb AMC, eds. Evidence-guided Prescribing of the Pill. Carnforth, UK: Parthenon Publishing 1996; 109-20
10. Speroff L, De Cherney A. The advisory board for the new progestin. Evaluation of a new generation of oral contraceptives. Obstet Gynecol 1993; 81: 1034-47
11. Consensus Development Meeting 1995: Combined oral contraceptives and cardiovascular disease. Consensus statement issued after the Second European Conference on Sex Steroids and Metabolism. Amsterdam 1995. Gynecol Endocrinol 1995; 10: 1-5
12. Chasan-Taber L, Stampfer MJ. Oral contraceptives and risk of arterial disease: epidemiological evidence on acute long-term effects. In Hannaford PC, Webb AMC, eds. Evidence-guided Prescribing of the Pill. Carnforth, UK: Parthenon Publishing 1996; 49-60
13. Katerndahl DA, Realini JP, Cohen PA. Oral contraceptive use and cardiovascular disease. Is the relationship real or due to study bias? J Fam Pract 1992; 35: 147-57
14. Stampfer MJ, Willet WC, Colditz CA, et al. A prospective study of past use of oral contraceptive agents and risk of cardiovascular disease. N Engl J Med 1988; 319: 1213-17
15. Creatsas G, Adamopoulos P, Eleptheriou N, et al. Clinical and metabolic effects of the monophasic gestodene/ethinylestradiol pill for contraception during adolescence. Adolesc Pediatr Gynecol 1991; 4: 76-81
16. Shaaban MM.The perimenopause and contraception. Maturitas 1996; 23: 181-92
17. van Lunsen HW. Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens. Eur J Contracept Reprod Health Care 1996; 1: 39-45
18. Leodolter S, Lidegaard O, Lopez P, et al. Global perspectives. Gynecol Forum 1996; 1(2): 18-26